|
Pharma
product development and commercialization are complex and demand broad expertise and cross-functional collaboration. ― End-to-end business toolkits are needed to develop and
commercialize products. They can provide needed guidance to teams and align the organization. Pharmaceutical
product launches are the most critical success factors to each company in the pharma business ― Detailed Toolkits, with timelines and roadmaps, can accelerate the strategic direction and alignment
to effectively plan and execute activities
New Product Launch Planning |
Unparalleled breadth of expertise in new Rx product launches in the US and EU. Launched
Pfizer's first billion dollar drugs (Procardia XL, Diflucan, Norvasc, Zithromax, Zoloft & Cardura). Roche Team recieved
HDMA DIANA award for Invirase launch in record time to AIDS clinics. Launched Anesta's Actiq globally from Salt Lake City
start-up operations. Succeeded with virutal supply chain operations for Sunovion's Latuda launch despite Japan's earthquake
& tsunami. ― Successfully
launched major branded drugs (Procardia XL, Diflucan, Norvasc, Zithromax, Zoloft, Invirase, Actiq and Latuda) while ensuring
effective teamwork on global/regional regulatory filings and approvals ― Scope of work: Development, Registration batches, CMC preparation, NDA/MAA filings, PAI inspection readiness, Approval
and Launch.
Supply Chain Operational Excellence and Virtual Infrastructure |
Global Pharmaceutical
Supply Chain Leader with expertise in global cGMP manufacturing operations, strategic sourcing, procurement,
production planning and inventory control, distribution, order gulgillment and order-to-cash. Extensive expertise
in building commercialization readiness for Rx pharmaceutical product launches. Experience in big pharma, drug delivery,
biotech, small and specialty pharma, and Japanese US subsidiaries. - 30+ years of BioPharmaindustry experience
at Pfizer, Roche, BMS, Anesta/Cephalon, Kyowa Hakko Kirin, Dainippon Sumitomo, and Braeburn Pharmaceuticals
- Held leadership (VP) positions and oversaw the development of end-to-end supply chain strategies and ran supply
chain operations across US, Europe and Asia
|
